SCHEMBL26597051

SCHEMBL26597051

CC(C)(C)n1c(=O)ccc2ccc(N)cc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRPF1 P55201 3/20 0.50
▸ ALDH1A1 P00352 5/20 0.38
▸ KDM4E B2RXH2 5/20 0.38
▸ MAPT P10636 4/20 0.38
▸ GAA P10253 1/20 0.38
▸ GFER P55789 1/20 0.38
▸ CA12 O43570 1/20 0.35
▸ BRD4 O60885 1/20 0.35
▸ CA9 Q16790 1/20 0.35
▸ KAT2B Q92831 1/20 0.35
▸ BRD9 Q9H8M2 1/20 0.35
▸ PRKCI P41743 1/20 0.34
▸ CYP2A6 P11509 1/20 0.34
▸ KEAP1 Q14145 1/20 0.34
▸ NSD2 O96028 1/20 0.33
▸ CYP3A4 P08684 3/20 0.32
▸ HSD17B10 Q99714 2/20 0.32
▸ CHEK1 O14757 1/20 0.32
▸ AURKA O14965 1/20 0.32
▸ DAPK3 O43293 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26597052 0.88 BRPF1 (0.62) BRPF1ALDH1A1KDM4EMAPTGAA
SCHEMBL17637285 0.79 HTR2C (0.37) BRPF1ALDH1A1KDM4ECA12BRD4
SCHEMBL11743970 0.76 BRPF1 (0.76) BRPF1ALDH1A1KDM4EMAPTGAA
SCHEMBL847600 0.76 CA12 (0.57) BRPF1ALDH1A1KDM4EMAPTCA12
SCHEMBL27769160 0.73 BRPF1 (0.52) BRPF1ALDH1A1KDM4EMAPTGAA
SCHEMBL26596969 0.70 PRKCI (0.44) BRPF1ALDH1A1KDM4EMAPTGAA
SCHEMBL12245375 0.69 NPC1 (0.41) BRPF1ALDH1A1KDM4EMAPTGAA
SCHEMBL7085783 0.67 BRPF1 (1.00) BRPF1ALDH1A1KDM4EMAPTGAA
SCHEMBL26597049 0.67 BRPF1 (0.34) BRPF1ALDH1A1CA12BRD4CA9
SCHEMBL26597053 0.67 ALDH1A1 (0.40) BRPF1ALDH1A1KDM4EMAPTCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11795192-B2 Antimicrobial compounds, compositions, and uses thereof Lakewood Amedex, Inc. (US) 2023-10-24 — — US disclosed
US-11795192-B2 Antimicrobial compounds, compositions, and uses thereof Lakewood Amedex, Inc. (US) 2023-10-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11795192-B2 Antimicrobial compounds, compositions, and uses thereof CAT, MPO, NISCH BRPF1 3507/4885ALDH1A1 2110/4885KDM4E 4759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback